Laboratorios Farmaceuticos Rovi (LABFF) Stock Price, News & Analysis

Company Overview

Laboratorios Farmacéuticos Rovi, S.A. is a Spain-based pharmaceutical company engaged in the research, development, manufacture and commercialization of prescription medicines and other healthcare products. The company focuses on specialty pharmaceuticals, with activities spanning proprietary drug development, marketing and pharmaceutical manufacturing services.

Rovi’s portfolio includes medicines for areas such as thrombosis and other hospital and specialist-care indications. Its products include bemiparin, marketed under the Hibor brand in various markets, as well as long-acting injectable treatments developed using its ISM drug-delivery technology, including products based on risperidone.

In addition to its own branded products, Rovi operates as a contract development and manufacturing organization, providing pharmaceutical manufacturing services, particularly for injectable medicines. The company serves healthcare markets in Spain and other international geographies, with operations and commercial reach across Europe and selected markets worldwide.

Rovi traces its origins to 1946 and is headquartered in Madrid, Spain. The company is led by Juan López-Belmonte Encina, who serves as chief executive officer and executive chairman.

Key Stats

• Today's Range: C$67.17 to C$67.17
• 50-Day Range: C$64.77 to C$67.17
• 52-Week Range: C$65.86 to C$67.17
• Volume: N/A
• Average Volume: 1,300 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Biotechnology
• Sub-Industry: Biotechnology
• Current Symbol: OTCMKTS:LABFF
• CIK: N/A
• Web: www.rovi.es
• Phone: 34 91 021 30 00
• Fax: N/A
• Employees: 2,232
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A